New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 14, 2014
07:33 EDTPTX, GSK, POZNPernix Therapeutics to make $3M payment to CPPIB Credit Investments
In connection with the assignment of the PDC Agreement, Pernix (PTX) shall make a payment of $3M to CPPIB Credit Investments Inc. and has also granted POZEN (POZN) a warrant to purchase 500,000 shares of Pernix common stock at an exercise price equal to the closing market price on May 13, 2014. The warrants will be exercisable from the closing date of the transaction until February 2018. The amended PDC Agreement provides for royalties of 18% of net sales with quarterly minimum royalty amounts of $4M for the calendar quarters commencing on January 1, 2015 and ending on March 31, 2018.
News For PTX;GSK;POZN From The Last 14 Days
Check below for free stories on PTX;GSK;POZN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 22, 2014
14:19 EDTGSKViiV Healthcare receives FDA approval for HIV-1 treatment Triumeq
Subscribe for More Information
August 20, 2014
15:35 EDTGSKGlaxoSmithKline receives FDA approval for Arnuity Ellipta in the U.S.
Subscribe for More Information
11:44 EDTGSKMylan completes second bidding round for GSK prescription portfolio, WSJ says
Mylan (MYL), TPG Capital, Advent International, KKR (KKR), Warburg Pincus and a few Indian prescription manufacturers have completed the second round of bidding for GlaxoSmith Kline's (GSK) portfolio of mature medications, according to The Wall Street Journal, citing people familiar with the sales process. GSK noted that it aims to sell a portfolio of drug brands in the U.S. and EU with yearly sales of approximately $1.66B. Reference Link
08:30 EDTPOZN, PTX, GSKPernix closes acquisition of Treximet
Subscribe for More Information
08:29 EDTGSK, PTXPernix Therapeutics to host conference call
Conference call to discuss acquisition of Treximet will be held on August 20 at 9 am. Webcast Link
08:24 EDTPTXPernix Therapeutics management to meet with Needham
Subscribe for More Information
08:08 EDTPTXPernix sees FY15 revenue approximately $230M, consensus $214.07M
Sees FY15 adjusted EBITDA $95M.
08:07 EDTPTXPernix Therapeutics sees FY14 revenue $110M-$120M, consensus $116.87M
Subscribe for More Information
08:04 EDTGSK, PTX, POZNPOZEN announces U.S. rights for Treximet acquired by Pernix Therapeutics
Subscribe for More Information
August 15, 2014
06:34 EDTGSKLawyer says GSK connected investigators to not appeal ruling, Reuters says
Defense lawyer Zhai Jian said GlaxoSmithKline connected corporate investigator Peter Humphrey and his American wife are not aiming to appeal a Chinese court's prison sentence ruling, according to Reuters, citing comments from Jian. Reference Link
August 13, 2014
16:19 EDTGSKOn The Fly: Closing Wrap
Subscribe for More Information
13:13 EDTGSKInterMune exploring sale after bids from Sanofi, Roche, Glaxo, Bloomberg says
InterMune (ITMN) is working with its financial advisers Goldman Sachs (GS) and Centerview Partners to evaluate takeover bids it has received from Sanofi (SNY), Roche (RHHBY), GlaxoSmithKline (GSK) and Actelion (ALIOF), said Bloomberg, citing people with knowledge of the matter. The report noted that one of the sources said Sanofi has so far shown the most interest in a deal for InterMune, whose shares are up more than 13% to $51.56 following the first headlines from the report. Reference Link
07:32 EDTPOZNHorizon Pharma, POZEN announce USPTO Notice of Allowance for VIMOVO
Subscribe for More Information
August 12, 2014
07:15 EDTGSKWHO says ethical to offer unproven interventions in light of Ebola outbreak
Subscribe for More Information
06:18 EDTGSKGSK CEO faces pressure as company deals with weak sales, allegations, WSJ says
Subscribe for More Information
August 11, 2014
12:57 EDTGSKGlaxoSmithKline facing new bribery allegations in Syria, Reuters reports
Subscribe for More Information
08:47 EDTGSKGlaxo to conduct Ebola vaccine trials later this year, Guardian says
Subscribe for More Information
08:37 EDTPTXPernix says closing of deal to acquire U.S. rights to Treximet delayed
Subscribe for More Information
08:34 EDTPTXPernix Therapeutics reports Q2 EPS (16c), two estimates (5c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use